Skip to main content
. 2017 Jun 20;7:3860. doi: 10.1038/s41598-017-04170-1

Figure 7.

Figure 7

AAV-shRNA treatment decreases the expression of liver fibrosis biomarkers in HBV-persistent mice. Mice received AAV2-shRNA treatment, and serum levels of TGF-β (a), collagen I (b), and collagen III (c) were measured by ELISA during a 6 month period. (dg) Reverse transcription quantitative PCR measurements of Tgf-β1 (d), Col I (e), Col III (f), and α-SMA (g) mRNA levels in the liver. (h) Western blot analysis of α-SMA in liver samples. Statistical analyses were performed using a two-way analysis of variance. P < 0.05: significant difference. Ns: the difference was not significant. Data represent the mean ± SD (n = 4).